drugset / Trial / NCT00227461
Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.
Non-randomizedCrossoverOpen-labelTreatment
Summary
The study investigates the possibility that levetiracetam may improve the symptoms of chronic post-stroke aphasia.
Timeline
- Start
- 2005-09
- Primary completion
- 2021-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1000 mg | Oral |